Who’s Driving? Switch of Drivers in Immunotherapy-Treated Progressing Sinonasal Melanoma

SIMPLE SUMMARY: Here, we monitored the course of the disease and treatment of sinonasal melanoma patients. Since treatment options are rare, immunotherapy is often the treatment of choice. However, intrinsic or acquired resistance to treatment may occur. We assessed the mutational status of the tumo...

Full description

Saved in:
Bibliographic Details
Published in:Cancers (Basel)
Main Authors: Freiberger, Sandra N., Turko, Patrick, Hüllner, Martin, Dummer, Reinhard, Morand, Grégoire B., Levesque, Mitchell P., Holzmann, David, Rupp, Niels J.
Format: Artigo
Language:Inglês
Published: MDPI 2021
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8198298/
https://ncbi.nlm.nih.gov/pubmed/34072863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13112725
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items